{
    "2020-05-24": [
        [
            {
                "time": "",
                "original_text": "【民生医药|周报】关注“补短板”，持续推荐API、CXO 和医疗器械板块",
                "features": {
                    "keywords": [
                        "民生医药",
                        "周报",
                        "补短板",
                        "API",
                        "CXO",
                        "医疗器械"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "API",
                        "CXO",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "百元股扩容至近70只 抓业绩搞价值投资才有出路",
                "features": {
                    "keywords": [
                        "百元股",
                        "扩容",
                        "业绩",
                        "价值投资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}